News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ophthotech Corporation (OPHT) Reports Second Quarter 2014 Financial Results And Provides Business Update


8/6/2014 9:24:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ophthotech Corporation (Nasdaq:OPHT) today provided an update on the Company’s business and announced financial results for the second quarter ended June 30, 2014.

Recent Highlights

•In May 2014, the Company entered into an ex-US licensing and commercialization agreement with Novartis Pharma AG focused on the treatment of wet age-related macular degeneration (AMD).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES